| Autor: |
Salarian, Sara, Raoufi, Masoomeh, Asgari, Sogol, Behnaz, Faranak, Lima, Behnam Safarpour |
| Předmět: |
|
| Zdroj: |
Journal of Cellular & Molecular Anesthesia; Jun2024, Vol. 9 Issue 2, p1-3, 3p |
| Abstrakt: |
Primary hyperhidrosis (PH) is a condition characterized by excessive sweating. Primary treatment options include antiperspirants or anticholinergics for symptomatic relief, while axillary and palmar hyperhidrosis can be addressed with surgery. Botulinum toxin type A (BTX-A) is a significant treatment option for these patients. This toxin inhibits the release of acetylcholine, preventing overactive eccrine sweat glands from causing excessive sweating. Despite its effectiveness in treating various neurological and cosmetic conditions, Botox may pose the risk of severe side effects resulting from local or systemic drug release. We report the case of a 21-year-old woman who developed weakness in all four limbs, dyspnea, dysphagia, and blurred vision two weeks after botulinum toxin injection for hyperhidrosis treatment. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
